Bio-Rad Laboratories Inc
(STU:BUWA)
€
344.3
4.8 (1.41%)
Market Cap: 9.37 Bil
Enterprise Value: 9.16 Bil
PE Ratio: 0
PB Ratio: 1.39
GF Score: 75/100 Bio Rad Laboratories Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 11, 2019 / 05:40PM GMT
Release Date Price:
€255.8
(+0.87%)
Patrick B. Donnelly
Goldman Sachs Group Inc., Research Division - Equity Analyst
All right. Great. Thanks for being here. I'm Patrick Donnelly, the tools and diagnostics analyst here at Goldman. Happy to have CEO and CFO of Bio-Rad up here, Norm and Ilan. It's certainly open Q&A, so if anyone has any questions in the audience, feel free to just raise your hands, and I'll call out to you. But Norm, maybe just to start, if you can kind of just talk us through the most recent results and then we can jump into Q&A from there.
Norman D. Schwartz
Bio-Rad Laboratories, Inc. - Chairman, CEO & President
So okay. So I think that you started out pretty well. I think we're pretty pleased with the results. I think that when you look around the world, the markets generally has seemed like they're pretty healthy for us for the year.
Questions & Answers
Patrick B. Donnelly
Goldman Sachs Group Inc., Research Division - Equity Analyst
Okay. And then maybe just on the operational side, obviously, we've seen
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot